Research & Development
29 October 2020 - - The New England Journal of Medicine has published data from the monotherapy arms of BLAZE-1, a Phase 2 study assessing the efficacy and safety of US-based pharmaceutical ...
29 October 2020 - - US-based biotechnology company Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has received written feedback to its Type B Pre-IND (Pre-Investigational New Drug application) meetin...
29 October 2020 - - The US Food and Drug Administration has issued Emergency Use Authorization to allow sample pooling with PerkinElmer New Coronavirus Nucleic Acid Detection Kit to inc...
29 October 2020 - Pharmaceutical company Astellas Pharma Inc (TSE:4503) reported on Wednesday the receipt of the US Food and Drug Administration's (FDA) Fast Track designation to expedite the dev...
29 October 2020 - Genetic analysis systems company Agena Bioscience reported on Wednesday the receipt of the Emergency Use Authorization from the US Food and Drug Administration (FDA) for its MassARRA...
29 October 2020 - United States-based PeproMene Bio Inc has submitted an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) to study a novel chimeric an...
Related Headlines